Nautilus Biotechnolgy, Inc. Common Stock (NAUT)
LABORATORY ANALYTICAL INSTRUMENTS
- Headquarters
- United States
- Employees
- 130
- Market Cap
- $131M
About Nautilus Biotechnolgy, Inc. Common Stock
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
SentiSense also tracks daily options readings for Nautilus Biotechnolgy, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Nautilus Biotechnolgy, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.